These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16128265)

  • 1. New adjuvants for parenteral and mucosal vaccines.
    Guy B; Burdin N
    Therapie; 2005; 60(3):235-41. PubMed ID: 16128265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological foundations to the quest for new vaccine adjuvants.
    Burdin N; Guy B; Moingeon P
    BioDrugs; 2004; 18(2):79-93. PubMed ID: 15046524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design.
    Ebensen T; Guzmán CA
    Hum Vaccin; 2008; 4(1):13-22. PubMed ID: 18376145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 12 and innate molecules for enhanced mucosal immunity.
    Boyaka PN; Lillard JW; McGhee J
    Immunol Res; 1999; 20(3):207-17. PubMed ID: 10741861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
    Wang X; Meng D
    Protein Cell; 2015 Mar; 6(3):170-84. PubMed ID: 25503634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines as adjuvants for the induction of mucosal immunity.
    Boyaka PN; McGhee JR
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):71-9. PubMed ID: 11516780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perfect mix: recent progress in adjuvant research.
    Guy B
    Nat Rev Microbiol; 2007 Jul; 5(7):505-17. PubMed ID: 17558426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
    Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
    Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine strategies: targeting helper T cell responses.
    Golding B; Scott DE
    Ann N Y Acad Sci; 1995 May; 754():126-37. PubMed ID: 7625646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.
    McCluskie MJ; Weeratna RD; Davis HL
    Vaccine; 2001 Mar; 19(17-19):2657-60. PubMed ID: 11257405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvanticity of anti-cD40 in vaccine development.
    Cairing J; Barr T; Heath AW
    Curr Opin Mol Ther; 2005 Feb; 7(1):73-7. PubMed ID: 15732532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors and T-helper-1/T-helper-2 responses.
    Dabbagh K; Lewis DB
    Curr Opin Infect Dis; 2003 Jun; 16(3):199-204. PubMed ID: 12821808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG DNA as a vaccine adjuvant.
    Klinman DM
    Expert Rev Vaccines; 2003 Apr; 2(2):305-15. PubMed ID: 12899580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.
    Madan-Lala R; Pradhan P; Roy K
    Sci Rep; 2017 May; 7(1):2530. PubMed ID: 28566683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
    Lawson LB; Norton EB; Clements JD
    Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses.
    Silva DG; Cooper PD; Petrovsky N
    Immunol Cell Biol; 2004 Dec; 82(6):611-6. PubMed ID: 15550119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.